CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $649,485 | -49.2% | 14,309 | -37.2% | 0.03% | +4.0% |
| Q2 2023 | $1,278,196 | +143.8% | 22,768 | +96.4% | 0.02% | -16.7% |
| Q1 2023 | $524,215 | -46.0% | 11,590 | -51.5% | 0.03% | 0.0% |
| Q4 2022 | $971,372 | +23.1% | 23,896 | +98.0% | 0.03% | -55.9% |
| Q3 2022 | $789,000 | +9.3% | 12,071 | +1.6% | 0.07% | +13.3% |
| Q2 2022 | $722,000 | +9.2% | 11,885 | +12.9% | 0.06% | +27.7% |
| Q1 2022 | $661,000 | +0.8% | 10,529 | +21.5% | 0.05% | 0.0% |
| Q4 2021 | $656,000 | -19.3% | 8,663 | +19.2% | 0.05% | -33.8% |
| Q3 2021 | $813,000 | -26.3% | 7,266 | +6.6% | 0.07% | -27.6% |
| Q2 2021 | $1,103,000 | +40.7% | 6,816 | +5.9% | 0.10% | +22.5% |
| Q1 2021 | $784,000 | -8.7% | 6,438 | +14.8% | 0.08% | -20.0% |
| Q4 2020 | $859,000 | +102.6% | 5,608 | +10.6% | 0.10% | +69.5% |
| Q3 2020 | $424,000 | +17.1% | 5,070 | +2.9% | 0.06% | +3.5% |
| Q2 2020 | $362,000 | +24.4% | 4,927 | -22.4% | 0.06% | +5.6% |
| Q1 2020 | $291,000 | +4.7% | 6,352 | +37.2% | 0.05% | -5.3% |
| Q4 2019 | $278,000 | -64.8% | 4,631 | -61.6% | 0.06% | -16.2% |
| Q3 2011 | $789,000 | – | 12,071 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |